Saluda Shares Hit Record Low on Evoke Device Recall
Saluda Medical shares dropped to a record low after the company recalled certain Evoke neurostimulation devices due to a manufacturing issue. The firm received twenty-six complaints out of thirty-nine hundred affected devices and is working with the FDA.
Saluda Medical shares fell to a record low of A$0.275 during Wednesday afternoon trading after the medical device maker announced a voluntary recall of certain Evoke neurostimulation systems. The sell-off comes following a manufacturing defect that impacts battery charging functionality in implanted units. The company operates across the United States and Australia to market its proprietary spinal cord stimulation technology.
